Evidence map›Paper›PMID 40191549›Full record

ArticleEuropean heart journal. Case reports2024

A perfect mimic: the role of multimodality imaging in right ventricular cardiomyopathy-a case report.

Dana Viskin, Michal Laufer-Perl, Yan Topilsky, Shmuel Banai, Shafik Khoury

Abstract readCase Reports
In one paragraph

Article in European heart journal. Case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dana ViskinDepartment of Cardiology, Tel Aviv Sourasky Medical Centre, Affiliated to Tel-Aviv University, 6 Weizmann Street, Tel Aviv 6423906, Israel.
Michal Laufer-PerlDepartment of Cardiology, Tel Aviv Sourasky Medical Centre, Affiliated to Tel-Aviv University, 6 Weizmann Street, Tel Aviv 6423906, Israel.
Yan TopilskyDepartment of Cardiology, Tel Aviv Sourasky Medical Centre, Affiliated to Tel-Aviv University, 6 Weizmann Street, Tel Aviv 6423906, Israel.ORCID https://orcid.org/0000-0002-2269-802X
Shmuel BanaiDepartment of Cardiology, Tel Aviv Sourasky Medical Centre, Affiliated to Tel-Aviv University, 6 Weizmann Street, Tel Aviv 6423906, Israel.
Shafik KhouryDepartment of Cardiology, Tel Aviv Sourasky Medical Centre, Affiliated to Tel-Aviv University, 6 Weizmann Street, Tel Aviv 6423906, Israel.ORCID https://orcid.org/0000-0001-5190-9407

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Distinguishing right ventricular cardiac sarcoidosis (RVCS) from arrhythmogenic right ventricular cardiomyopathy (ARVC) is often a challenging task particularly when imaging findings are limited to the right ventricle and when electrocardiographic and arrhythmic findings are typical for ARVC. Here, we discuss the challenges of diagnosis and management in a patient whose initial work-up strongly suggested ARVC and was later diagnosed with cardiac sarcoidosis (CS), highlighting the role of multimodality imaging. Case summary: On presentation, this patient displayed electrocardiographic abnormalities, arrhythmia morphology, and cardiac magnetic resonance imaging findings consistent with the criteria for a definite diagnosis of ARVC. However, through the use of multimodal imaging, a final diagnosis of CS was made. Subsequent immunosuppressive treatment effectively managed the inflammation, and as a primary prevention measure, an implantable cardioverter-defibrillator was implanted. Almost 2 years following the initial presentation, the patient received an appropriate shock from the device, attributed to rapid ventricular tachycardia arising from myocardial scarring. Discussion: Right ventricular cardiac sarcoidosis can closely resemble ARVC, making it challenging to distinguish between the two. Multimodality imaging is pivotal for accurate diagnosis and risk assessment, as well as for adjusting immunosuppressive therapy and monitoring response to treatment in CS.

Indexed as

ARVCCase reportRight ventricular cardiomyopathySarcoidosis

Identifiers

PMID40191549
PMCPMC11969212

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.